创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

ZHANG Hui, LIU Jianyang, MAO Qunying, LIANG Zhenglun, XU Miao. Advances in Quality Control of mRNA Vaccine[J]. Progress in Pharmaceutical Sciences, 2022, 46(10): 745-750. DOI: 10.20053/j.issn1001-5094.2022.10.004
Citation: ZHANG Hui, LIU Jianyang, MAO Qunying, LIANG Zhenglun, XU Miao. Advances in Quality Control of mRNA Vaccine[J]. Progress in Pharmaceutical Sciences, 2022, 46(10): 745-750. DOI: 10.20053/j.issn1001-5094.2022.10.004

Advances in Quality Control of mRNA Vaccine

  • mRNA vaccines are characterized by rapid research and development, short production cycle and easy large-scale production. However, as a new type of vaccines, there is still a lack of systematic study data and experience in their quality control. This article reviews the guidance documents and literature related to the quality control of mRNA vaccines, and summarizes the key considerations in product quality control items and acceptance criteria, detection methods and standards, aiming to provide reference for the quality control of mRNA vaccines.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return